Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, Dec. 21, 2015 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”), a Fortress Biotech (NASDAQ:FBIO) Company, announced today that it has closed on a total of $58 million,...
-
NEW YORK, Oct. 16, 2015 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint"), a Fortress Biotech Company (NASDAQ:FBIO), today announced that Mr. James F. Oliviero, III, has been appointed...
-
NEW YORK, Sept. 8, 2015 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint"), a Fortress Biotech Company, (NASDAQ:FBIO) announced that it filed a registration statement on Form 10 with the...